LFCR LIFECORE BIOMEDICAL, INC. DE

8-K Current Report

Filed: March 5, 2026

Health Care

Pharmaceutical Preparations

LIFECORE BIOMEDICAL, INC. DE (LFCR) 8-K current report filed with SEC EDGAR on March 5, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 5.08: Shareholder Director Nominations

AI Filing Analysis
8-K

Item 5.08 · Shareholder Director Nominations

• Fiscal year changed from last-Sunday-of-May end to calendar year (Dec 31), effective for transition period May 26–Dec 31, 2025
• 2026 Annual Meeting set for June 4, 2026 — shifted >30 days from prior year's Oct 29, 2025 meeting date

+1 more insights

Other LIFECORE BIOMEDICAL, INC. DE 8-K Filings

8-K Mar 16, 2026

Get deeper insights on LIFECORE BIOMEDICAL, INC. DE

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.